A New Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

被引:0
|
作者
Miura, Katsuhiro [1 ]
Konishi, Jun [2 ]
Miyake, Takaaki [3 ]
Masanori, Makita [4 ]
Hojo, Atsuko [5 ]
Masaki, Yasufumi [6 ]
Uno, Masatoshi [7 ]
Ozaki, Jun [8 ]
Yoshida, Chikamasa [9 ]
Niiya, Daigo [10 ]
Kitazume, Koichi [11 ]
Maeda, Yoshinobu [12 ]
Takizawa, Jun [13 ]
Sakai, Rika [14 ]
Nawa, Yuichiro [15 ]
Yano, Tomofumi [10 ]
Yamamoto, Kazuhiko [4 ]
Sunami, Kazutaka [2 ]
Hiramatsu, Yasushi [16 ]
Aoyama, Kazutoshi [17 ]
Tsujimura, Hideki [18 ]
Hatta, Yoshihiro [1 ]
Kanno, Masatoshi [19 ]
机构
[1] Nihon Univ, Sch Med, Dept Hematol & Rheumatol, Tokyo, Japan
[2] Natl Hosp Org Okayama Med Ctr, Dept Hematol, Okayama, Japan
[3] Shimane Univ Hosp, Dept Oncol Hematol, Izumo, Shimane, Japan
[4] Okayama City Hosp, Dept Hematol, Okayama, Japan
[5] Kasukabe Municipal Hosp, Div Hematol & Oncol, Saitama, Japan
[6] Kanazawa Med Univ, Dept Hematol & Immunol, Uchinada, Ishikawa 92002, Japan
[7] Kaneda Hosp, Div Internal Med, Okayama, Japan
[8] Toyama Prefectural Cent Hosp, Dept Hematol, Toyama, Japan
[9] Natl Hosp Org Minami Okayama Med Ctr, Dept Hematol, Okayama, Japan
[10] Okayama Rosai Hosp, Dept Hematol, Okayama, Japan
[11] Showa Gen Hosp, Dept Hematol, Tokyo, Japan
[12] Okayama Univ, Dept Hematol & Oncol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan
[13] Niigata Univ, Fac Med, Dept Hematol Endocrinol & Metab, Niigata, Japan
[14] Kanagawa Canc Ctr, Dept Med Oncol, Yokohama, Kanagawa 2410815, Japan
[15] Ehime Prefectural Cent Hosp, Div Hematol, Matsuyama, Ehime, Japan
[16] Himeji Red Cross Hosp, Dept Haematol & Oncol, Himeji, Hyogo, Japan
[17] Chugoku Cent Hosp, Dept Hematol, Hiroshima, Japan
[18] Chiba Canc Ctr, Dept Hematol Oncol, Chiba 2608717, Japan
[19] Nara Med Univ Hosp, Ctr Oncol, Kashihara, Nara, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [1] The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Castillo, Jorge J.
    Beltran, Brady E.
    Song, Moo-Kon
    Ilic, Ivana
    Leppa, Sirpa
    Nurmi, Heidi
    Seki, Ritsuko
    Uccella, Silvia
    Li, Jun-Min
    Treaba, Diana O.
    Stachurski, Dariusz
    Butera, James N.
    [J]. LEUKEMIA RESEARCH, 2012, 36 (04) : 413 - 417
  • [2] PROGNOSTIC SIGNIFICANCE OF IMMUNOHISTOCHEMICAL MARKERS IN R-CHOP TREATED DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS
    Picleanu, A. -M.
    Patrascu, S.
    Mogoanta, L.
    [J]. HAEMATOLOGICA, 2017, 102 : 826 - 827
  • [3] PROGNOSTIC SIGNIFICANCE OF SARCOPENIA IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB PLUS CHOP (R-CHOP)
    Go, S. I.
    Park, M. J.
    Kim, H. G.
    Kang, M. H.
    Lee, G. W.
    [J]. HAEMATOLOGICA, 2016, 101 : 686 - 687
  • [4] Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma
    Choi, Soyeon
    Lee, Yoo Jin
    Choi, Yunsuk
    Kim, Misung
    Kim, Hyun-Jung
    Kim, Ji Eun
    Oh, Sukjoong
    Chae, Seoung Wan
    Cha, Hee Jeong
    Jo, Jae-Cheol
    [J]. JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2022, 56 (05) : 281 - 288
  • [5] Prognostic Impact of Tumor Microenvironment on Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Gomez-Gelvez, J. C.
    Salama, M.
    Cogan, C.
    Leavitt, M.
    Inamdar, K.
    [J]. LABORATORY INVESTIGATION, 2013, 93 : 329A - 329A
  • [6] Prognostic Impact of Tumor Microenvironment on Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Gomez-Gelvez, J. C.
    Salama, M.
    Cogan, C.
    Leavitt, M.
    Inamdar, K.
    [J]. MODERN PATHOLOGY, 2013, 26 : 329A - 329A
  • [7] Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP
    Nyman, Heidi
    Jerkeman, Mats
    Karjalainen-Lindsberg, Marja-Liisa
    Banham, Alison H.
    Leppa, Sirpa
    [J]. MODERN PATHOLOGY, 2009, 22 (08) : 1094 - 1101
  • [8] Enhancement of the International Prognostic Index with hematologic parameters: A new prognostic model for diffuse large B-cell lymphoma treated with R-CHOP
    Chen, H.
    Zhong, Q.
    Qin, Y.
    Yang, J.
    Liu, P.
    He, X.
    Zhou, S.
    Zhang, C.
    Gui, L.
    Yang, S.
    Zhou, L.
    Shi, Y.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S776 - S777
  • [9] Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP
    Hui, D.
    Proctor, B.
    Donaldson, J.
    Shenkier, T.
    Hoskins, P.
    Klasa, R.
    Savage, K.
    Gascoyne, R.
    Connors, J. M.
    Sehn, L. L.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 186 - 187
  • [10] Prognostic utility of extranodal disease involvement in diffuse large B-cell lymphoma in patients treated with R-CHOP
    Hui, David
    Donaldson, Jane
    Hoskins, Paul
    Klasa, Richard
    Savage, Kerry J.
    Shenkier, Tamara
    Gascoyne, Randy D.
    Connors, Joseph M.
    Sehn, Laurie
    [J]. BLOOD, 2007, 110 (11) : 467A - 467A